Shrikant Jadhav
About Shrikant Jadhav
Shrikant Jadhav is a Research Associate I at Nektar Therapeutics, based in South San Francisco, California. He holds a Master's degree in Pharmacy and has over a decade of experience in the pharmaceutical industry, including previous work in bioanalytical research at Raptim Research Ltd.
Work at Nektar Therapeutics
Shrikant Jadhav has been employed at Nektar Therapeutics since 2012, serving as a Research Associate I. His role involves contributing to research and development efforts within the pharmaceutical industry. Based in South San Francisco, California, Jadhav has been part of a team that focuses on innovative solutions in biotechnology and pharmaceuticals. His tenure at Nektar Therapeutics spans over a decade, reflecting his commitment to advancing pharmaceutical research.
Education and Expertise
Shrikant Jadhav holds a Master of Pharmacy degree from Sharad Pawar College of Pharmacy, where he studied from 2010 to 2012. He also earned a Bachelor of Pharmacy degree from Shivaji University. His educational background provides a strong foundation in pharmaceutical sciences, complemented by his expertise in bioanalytical research gained during his previous role at Raptim Research Ltd. Jadhav's academic qualifications support his contributions to the field of pharmaceutical research.
Background
Shrikant Jadhav is based in South San Francisco, California, a prominent location for biotechnology and pharmaceutical companies. He began his career in the pharmaceutical industry at Raptim Research Ltd., where he worked in bioanalytical research from 2011 to 2012. His experience in this area has been instrumental in shaping his current role at Nektar Therapeutics, where he continues to apply his skills and knowledge.
Previous Employment at Raptim Research Ltd.
Before joining Nektar Therapeutics, Shrikant Jadhav worked at Raptim Research Ltd. as a bioanalytical researcher from 2011 to 2012. This position provided him with valuable experience in the field of bioanalysis, which he has leveraged in his subsequent role at Nektar Therapeutics. His time at Raptim Research Ltd. contributed to his understanding of analytical techniques and methodologies relevant to pharmaceutical research.